GlassScriptPhysician profile
Leena Shah
NPI 1194258343
$850.75
in general payments reported to CMS, 2019-2025
17 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.00 · 2023: $345 · 2024: $257 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $146.90 | 2023-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $132.33 | 2022-2025 | Zepbound, Mounjaro, Trulicity |
| Medtronic, INC. | $90.44 | 2024-2025 | Minimed 780g |
| Novo Nordisk INC | $89.49 | 2023-2024 | Rybelsus, Ozempic |
| Corcept Therapeutics | $81.48 | 2024 | Korlym |
| Amgen INC. | $48.66 | 2023-2024 | Evenity, Prolia, Tepezza |
| Sequel Med Tech, LLC | $40.32 | 2025 | Twiist |
| Sanofi-Aventis U.S. LLC | $37.71 | 2023 | |
| Xeris Pharmaceuticals, INC. | $37.00 | 2023 | Gvoke Hypopen |
| Ascendis Pharma Endocrinology INC | $35.84 | 2025 | Yorvipath |
| Bayer Healthcare Pharmaceuticals INC. | $21.51 | 2023 | |
| Embecta Corp. | $17.00 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Recordati_rare_diseases_inc. | $16.71 | 2025 | Isturisa |
| Alexion Pharmaceuticals, INC. | $16.57 | 2023 | Strensiq |
| Intuity Medical INC | $14.41 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.55 | 2023 | Lokelma |
| Beta Bionics, INC. | $10.83 | 2023 | Ilet Bionic Pancreas |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leena Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.